Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MOVU is an ophthalmic medical-device business focused on advanced optical imaging systems for eye care, operating as a medical brand/business unit within the Santec group. The company commercializes the ARGOS swept-source OCT biometer for cataract measurement and surgical planning, and is developing ARGONAUT, a next-generation whole-eye imaging system that combines seven imaging modalities in a single scan with AI-enabled analysis. Its core technologies include swept-source OCT, tunable VCSEL lasers, proprietary image-processing algorithms, and multimodal deep learning. MOVU positions its products around earlier and more accurate diagnosis, streamlined clinic workflow, and the ability to classify chronic disease risk from retinal and ocular imaging. The company appears active and privately held within Santec's corporate structure rather than as a stand-alone public biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MOVU.